This specific MICB‐vax vaccine applies the α3 domain of MICB to induces high‐titer antibodies targeting the highly conserved α3 domain (Figure 7), then the antibodies strongly bind to tumor cells expressing human MICB and prevent its shedding.250. This evidence concerns the gene MICB and neoplasm.